News & Perspective

Dec 11, 2008

Dec 11, 2008

Half-dose flu shots could help prevent shortages

(CIDRAP News) – Half-dose influenza shots generate nearly as strong an immune response in young adults as full-dose shots do, suggesting that cutting the dose in half may be a good way to cope with vaccine shortages, according to a study published this week.

Oct 02, 2008

Oct 02, 2008

Study: First flu wave in 1918 was vaccine for some

(CIDRAP News) – In the influenza pandemic of 1918, those who got sick in the first wave of illness were up to 94% less likely to fall ill when the second and much more severe wave struck, according to a new analysis of historical data.

Sep 26, 2008

Sep 26, 2008

Emergent garners $29 million for new anthrax vaccine

(CIDRAP News) – Emergent BioSolutions announced today that it has received a $29.7 million contract from the federal government to continue work on another of its next-generation anthrax vaccine candidates.

Sep 11, 2008

Sep 11, 2008

Firm wins $65 million contract for botulism treatments

(CIDRAP News) – Xoma Ltd., a Berkeley, Calif., pharmaceutical company, recently announced that it received a $65 million multiyear federal contract to fund work on botulinum antitoxins, one of which it hopes to put through safety and efficacy tests starting in 2009.

Sep 09, 2008

Sep 09, 2008

HHS funds work on new anthrax antitoxin

(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.

Sep 05, 2008

Sep 05, 2008

Firm wins $55 million contract for smallpox drug

(CIDRAP News) – SIGA Technologies Inc. announced this week that it has been awarded a $55 million federal contract to develop a new formulation of its experimental smallpox drug, called ST-246, and carry out related efforts.

The company, based in New York City, said it had previously received a $16.5 million contract to develop the drug, described as "a potent, non-toxic inhibitor of orthopoxviruses."

Aug 26, 2008

Aug 26, 2008

Anthrax probe prompts concerns about military labs

(CIDRAP News) –US Navy and Air Force officials recently reported a suspension of work in their biodefense laboratories to allow a thorough review of safety procedures, following the Army's announcement in early August that it would review security measures at the lab that housed the work of the late Bruce E. Ivins, whom federal officials believe played a role in the 2001 anthrax attacks.

Aug 22, 2008

Aug 22, 2008

Study: Bacterial pneumonia was main killer in 1918 flu pandemic

(CIDRAP News) – It was secondary bacterial pneumonia—not the influenza virus by itself—that killed most of the millions who perished in the 1918 flu pandemic, which suggests that current pandemic preparations should include stockpiling of antibiotics and bacterial vaccines, influenza researchers reported this week.

Aug 19, 2008

Aug 19, 2008

Researchers find long-lived immunity to 1918 pandemic virus

(CIDRAP News) – A study of the blood of older people who survived the 1918 influenza pandemic reveals that antibodies to the strain have lasted a lifetime and can perhaps be engineered to protect future generations against similar strains.

Aug 14, 2008

Aug 14, 2008

Researchers probe pandemic potential of H9N2 virus

(CIDRAP News) – Scientists have warned it's impossible to predict which avian influenza virus will spark the next pandemic, and while most of the attention has been on highly pathogenic H5N1, one research group is reporting new findings that raise concerns about the threat from the low-pathogenic H9N2 virus.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»